Initial aspirin dose and outcome among ST-elevation myocardial infarction patients treated with fibrinolytic therapy
JS Berger, A Stebbins, CB Granger, EM Ohman… - Circulation, 2008 - Am Heart Assoc
… mortality and bleeding risks associated with the initial use of … and Tissue Plasminogen
Activator for Occluded Coronary … Events (CURE) investigators 40 noted increased bleeding risks …
Activator for Occluded Coronary … Events (CURE) investigators 40 noted increased bleeding risks …
Long-term outcome and its predictors among patients with ST-segment elevation myocardial infarction complicated by shock: insights from the GUSTO-I trial
M Singh, J White, D Hasdai, PK Hodgson… - Journal of the American …, 2007 - jacc.org
… -Type Plasminogen Activator for Occluded Coronary Arteries)… , active bleeding, previous
treatment with streptokinase or … subgroup not addressed in contemporary guidelines. Among all …
treatment with streptokinase or … subgroup not addressed in contemporary guidelines. Among all …
Time to treatment with thrombolytic therapy: determinants and effect on short-term nonfatal outcomes of acute myocardial infarction
JL Cox, E Lee, A Langer, PW Armstrong, CD Naylor - Cmaj, 1997 - Can Med Assoc
… the risk of hemorrhagic stroke induced by thrombolytic therapy, … In one trial, the investigators
were able to compare … Acute myocardial infarction: contemporary risk and management …
were able to compare … Acute myocardial infarction: contemporary risk and management …
Clinical perspectives and therapeutics of thrombolysis
IA Khan, RM Gowda - International journal of cardiology, 2003 - Elsevier
… the thrombolysis in the treatment of myocardial infarction and … principle of modern thrombolytic
therapy is the use of agents, … hemorrhage is higher with tissue plasminogen activator than …
therapy is the use of agents, … hemorrhage is higher with tissue plasminogen activator than …
Thrombolytic therapy: clinical applications
WF Baker - Hematology/Oncology Clinics, 2003 - hemonc.theclinics.com
… patients who present with acute myocardial infarction (AMI). … and other sites of occult
hemorrhage, compatible with acute … All plasminogen activators possess an active site and fibrin …
hemorrhage, compatible with acute … All plasminogen activators possess an active site and fibrin …
… influence of time-to-treatment interval on myocardial salvage in patients with acute myocardial infarction treated with coronary artery stenting or thrombolysis
A Schömig, G Ndrepepa, J Mehilli, M Schwaiger… - Circulation, 2003 - Am Heart Assoc
… Thrombolysis in Myocardial Infarction (TIMI) investigators … 3 months), active bleeding or
bleeding diathesis, trauma or major … tissue plasminogen activator and intravenous streptokinase. …
bleeding diathesis, trauma or major … tissue plasminogen activator and intravenous streptokinase. …
Influence of diabetes mellitus on clinical outcome in the thrombolytic era of acute myocardial infarction
…, RM Califf, EJ Topol, GUSTO-I Investigators - Journal of the American …, 1997 - jacc.org
… contemporary relation between diabetes and outcome after … tissue-type plasminogen
activator (t-PA), streptokinase or a … Global Utilization of Streptokinase and Tissue Plasminogen …
activator (t-PA), streptokinase or a … Global Utilization of Streptokinase and Tissue Plasminogen …
Link between the angiographic substudy and mortality outcomes in a large randomized trial of myocardial reperfusion: importance of early and complete infarct artery …
RJ Simes, EJ Topol, DR Holmes Jr, HD White… - Circulation, 1995 - Am Heart Assoc
… comparison of streptokinase vs tissue plasminogen activator vs … myocardial infarction.
Lancet.1992; 339:753-770. Crossref… coronary patency, infarct size, and bleeding complications …
Lancet.1992; 339:753-770. Crossref… coronary patency, infarct size, and bleeding complications …
The Role of Thrombolytic Therapy in the Era of STEMI Interventions
N Mercado, TL Schreiber… - Manual of STEMI …, 2017 - Wiley Online Library
… Plasminogen Activator for Occluded Coronary Arteries) trial … with streptokinase, front‐loaded
tissue plasminogen activator (… reteplase with alteplase for acute myocardial infarction. The …
tissue plasminogen activator (… reteplase with alteplase for acute myocardial infarction. The …
Predictors of 30-day mortality in the era of reperfusion for acute myocardial infarction: results from an international trial of 41 021 patients
KL Lee, LH Woodlief, EJ Topol, WD Weaver, A Betriu… - Circulation, 1995 - Am Heart Assoc
… after intravenous tissue plasminogen activator in acute … J, for the MITI Project Investigators.
Hospital mortality in acute … except for a higher incidence of hemorrhagic stroke. Circulation.…
Hospital mortality in acute … except for a higher incidence of hemorrhagic stroke. Circulation.…